• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭中通气效率的决定因素:右心室功能和肺血管张力的作用。

Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.

作者信息

Lewis Gregory D, Shah Ravi V, Pappagianopolas Paul P, Systrom David M, Semigran Marc J

机构信息

Cardiology Division, Department of Medicine, and Pulmonary and Critical Care Unit, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Circ Heart Fail. 2008 Nov;1(4):227-33. doi: 10.1161/CIRCHEARTFAILURE.108.785501.

DOI:10.1161/CIRCHEARTFAILURE.108.785501
PMID:19808296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2806812/
Abstract

BACKGROUND

Ventilatory efficiency, right ventricular (RV) function, and secondary pulmonary hypertension are each prognostic indicators in patients with heart failure due to left ventricular systolic dysfunction, but the relationships among these variables have not been comprehensively investigated. In this study, we hypothesized that inefficient ventilation during exercise, as defined by an abnormally steep relationship between ventilation and carbon dioxide output (Ve/Vco(2) slope), may be a marker of secondary pulmonary hypertension and RV dysfunction in heart failure.

METHODS AND RESULTS

A cohort of patients with systolic heart failure (mean+/-SD age, 58+/-13 years; left ventricular ejection fraction, 0.27+/-0.05; peak oxygen uptake, 11.2+/-3.2 mL kg(-1) min(-1)) underwent incremental cardiopulmonary exercise testing with simultaneous hemodynamic monitoring and first-pass radionuclide ventriculography before and after 12 weeks of treatment with sildenafil, a selective pulmonary vasodilator, or placebo. Ve/Vco(2) slope was positively related to rest and exercise pulmonary vascular resistance (R=0.39 and R=0.60, respectively) and rest pulmonary capillary wedge pressure (R=0.49, P<0.005 for all) and weakly indirectly related to peak exercise RV ejection fraction (R=-0.29, P=0.03). Over the 12-week study period, Ve/Vco(2) slope fell 8+/-3% (P=0.02) with sildenafil and was unchanged with placebo. Changes in Ve/Vco(2) slope correlated with changes in exercise pulmonary vascular resistance (R=0.69, P<0.001) and rest and exercise RV ejection fraction (R=-0.58 and -0.40, respectively, both P<0.05).

CONCLUSIONS

In patients with systolic heart failure and secondary pulmonary hypertension, ventilatory efficiency is closely related to RV function and pulmonary vascular tone during exercise.

摘要

背景

通气效率、右心室(RV)功能和继发性肺动脉高压均为左心室收缩功能障碍所致心力衰竭患者的预后指标,但这些变量之间的关系尚未得到全面研究。在本研究中,我们假设运动期间通气效率低下,即通气与二氧化碳排出量之间关系异常陡峭(Ve/Vco₂斜率),可能是心力衰竭患者继发性肺动脉高压和RV功能障碍的一个标志。

方法与结果

一组收缩性心力衰竭患者(平均±标准差年龄,58±13岁;左心室射血分数,0.27±0.05;峰值摄氧量,11.2±3.2 mL·kg⁻¹·min⁻¹)在接受选择性肺血管扩张剂西地那非或安慰剂治疗12周前后,进行递增式心肺运动试验,同时进行血流动力学监测和首次通过放射性核素心室造影。Ve/Vco₂斜率与静息和运动时的肺血管阻力呈正相关(分别为R = 0.39和R = 0.60),与静息肺毛细血管楔压呈正相关(R = 0.49,P均<0.005),与运动高峰时RV射血分数呈弱间接相关(R = -0.29,P = 0.03)。在为期12周的研究期间,西地那非治疗使Ve/Vco₂斜率下降8±3%(P = 0.02),安慰剂治疗则无变化。Ve/Vco₂斜率的变化与运动肺血管阻力的变化相关(R = 0.69,P<0.001),与静息和运动时RV射血分数的变化相关(分别为R = -0.58和-0.40,P均<0.05)。

结论

在收缩性心力衰竭和继发性肺动脉高压患者中,运动期间通气效率与RV功能及肺血管张力密切相关。

相似文献

1
Determinants of ventilatory efficiency in heart failure: the role of right ventricular performance and pulmonary vascular tone.心力衰竭中通气效率的决定因素:右心室功能和肺血管张力的作用。
Circ Heart Fail. 2008 Nov;1(4):227-33. doi: 10.1161/CIRCHEARTFAILURE.108.785501.
2
Pulmonary Vascular Distensibility Predicts Pulmonary Hypertension Severity, Exercise Capacity, and Survival in Heart Failure.肺血管扩张性可预测心力衰竭患者的肺动脉高压严重程度、运动能力及生存率。
Circ Heart Fail. 2016 Jun;9(6). doi: 10.1161/CIRCHEARTFAILURE.115.003011.
3
Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.射血分数保留的心力衰竭患者右心室-肺动脉耦联受损及西地那非的作用:舒张性心力衰竭磷酸二酯酶-5抑制改善临床状态和运动能力(RELAX)试验的一项辅助分析
Circ Heart Fail. 2016 Apr;9(4):e002729. doi: 10.1161/CIRCHEARTFAILURE.115.002729.
4
The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.西地那非抑制磷酸二酯酶-5对慢性心力衰竭患者肺血流动力学、弥散能力、运动通气效率及摄氧动力学的影响
J Am Coll Cardiol. 2004 Dec 21;44(12):2339-48. doi: 10.1016/j.jacc.2004.09.041.
5
Ventilatory efficiency and dyspnea on exertion improvements are related to reduced pulmonary pressure in heart failure patients receiving Sildenafil.接受西地那非治疗的心力衰竭患者,其通气效率和运动时呼吸困难的改善与肺压降低有关。
Int J Cardiol. 2010 Oct 29;144(3):410-2. doi: 10.1016/j.ijcard.2009.03.041. Epub 2009 Mar 28.
6
Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.西地那非可改善收缩性心力衰竭患者的运动血流动力学和摄氧量。
Circulation. 2007 Jan 2;115(1):59-66. doi: 10.1161/CIRCULATIONAHA.106.626226. Epub 2006 Dec 18.
7
Effects of pulmonary vasodilator therapy on ventilatory efficiency during exercise in adults with Eisenmenger syndrome.肺血管扩张剂治疗对艾森曼格综合征成年患者运动期间通气效率的影响。
Congenit Heart Dis. 2011 Mar-Apr;6(2):139-46. doi: 10.1111/j.1747-0803.2011.00490.x. Epub 2011 Mar 21.
8
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.西地那非可改善收缩性心力衰竭合并继发性肺动脉高压患者的运动能力和生活质量。
Circulation. 2007 Oct 2;116(14):1555-62. doi: 10.1161/CIRCULATIONAHA.107.716373. Epub 2007 Sep 4.
9
Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study.射血分数保留的心力衰竭中的肺动脉高压:一项为期 1 年的磷酸二酯酶-5 抑制研究的靶点。
Circulation. 2011 Jul 12;124(2):164-74. doi: 10.1161/CIRCULATIONAHA.110.983866. Epub 2011 Jun 27.
10
Right ventricular diastolic dysfunction and the acute effects of sildenafil in pulmonary hypertension patients.右心室舒张功能障碍及西地那非对肺动脉高压患者的急性影响。
Chest. 2007 Jul;132(1):11-7. doi: 10.1378/chest.06-1263.

引用本文的文献

1
Central and Peripheral Mechanisms of Low Exercise Capacity in Prematurely Born Adults.早产成年人运动能力低下的中枢和外周机制
Compr Physiol. 2025 Oct;15(5):e70049. doi: 10.1002/cph4.70049.
2
Optimizing the Interpretation of Cardiopulmonary Exercise Testing in Endurance Athletes: Precision Approach for Health and Performance.优化耐力运动员心肺运动试验的解读:健康与表现的精准方法
Transl Sports Med. 2025 Aug 20;2025:5904935. doi: 10.1155/tsm2/5904935. eCollection 2025.
3
Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure.心力衰竭患者对运动和活动反应的生理表型分析
Circ Res. 2025 Jul 7;137(2):290-315. doi: 10.1161/CIRCRESAHA.125.325534. Epub 2025 Jul 3.
4
Exercise Training in Heart Failure: Clinical Benefits and Mechanisms.心力衰竭中的运动训练:临床益处与机制
Circ Res. 2025 Jul 7;137(2):273-289. doi: 10.1161/CIRCRESAHA.124.325533. Epub 2025 Jul 3.
5
V, Ve/V, and Cardiac Remodeling Correlate with Long-Term Cardiovascular Outcome in Heart Failure Patients.V、Ve/V与心脏重塑与心力衰竭患者的长期心血管结局相关。
J Cardiovasc Dev Dis. 2025 May 2;12(5):174. doi: 10.3390/jcdd12050174.
6
Cardiopulmonary Exercise Testing in Patients with Chronic Kidney Disease.慢性肾脏病患者的心肺运动试验
Cardiorenal Med. 2025;15(1):510-525. doi: 10.1159/000546201. Epub 2025 May 24.
7
Key Resting Echocardiographic Parameters for the Estimation of Exercise Parameters of Peak VO2, Heart Rate Recovery, and Ventilatory Efficiency.用于评估峰值摄氧量、心率恢复和通气效率等运动参数的关键静息超声心动图参数。
J Clin Med. 2025 Apr 27;14(9):3013. doi: 10.3390/jcm14093013.
8
Cardiopulmonary exercise capacity markers and their link to symptom burden in patients at risk for heart failure with non-reduced ejection fraction.射血分数正常的心力衰竭高危患者的心肺运动能力标志物及其与症状负担的关联。
Sci Rep. 2025 Mar 15;15(1):8940. doi: 10.1038/s41598-025-94172-1.
9
Exercise Pulmonary Hypertension and Beyond: Insights in Exercise Pathophysiology in Pulmonary Arterial Hypertension (PAH) from Invasive Cardiopulmonary Exercise Testing.运动性肺动脉高压及其他:有创心肺运动试验对肺动脉高压(PAH)运动病理生理学的见解
J Clin Med. 2025 Jan 26;14(3):804. doi: 10.3390/jcm14030804.
10
Cardiopulmonary exercise testing as a prognosis-assessing tool in heart failure with preserved ejection fraction.心肺运动试验作为射血分数保留的心力衰竭的预后评估工具。
ESC Heart Fail. 2025 Jun;12(3):2098-2106. doi: 10.1002/ehf2.15219. Epub 2025 Jan 16.

本文引用的文献

1
Long-term use of sildenafil in the therapeutic management of heart failure.西地那非在心力衰竭治疗管理中的长期应用。
J Am Coll Cardiol. 2007 Nov 27;50(22):2136-44. doi: 10.1016/j.jacc.2007.07.078. Epub 2007 Nov 13.
2
Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.西地那非可改善收缩性心力衰竭合并继发性肺动脉高压患者的运动能力和生活质量。
Circulation. 2007 Oct 2;116(14):1555-62. doi: 10.1161/CIRCULATIONAHA.107.716373. Epub 2007 Sep 4.
3
Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.急性西地那非对心力衰竭患者内皮介导的麦角反射调节及运动通气的改善作用。
Clin Pharmacol Ther. 2008 Feb;83(2):336-41. doi: 10.1038/sj.clpt.6100306. Epub 2007 Jul 25.
4
Development of a ventilatory classification system in patients with heart failure.心力衰竭患者通气分类系统的开发。
Circulation. 2007 May 8;115(18):2410-7. doi: 10.1161/CIRCULATIONAHA.107.686576. Epub 2007 Apr 23.
5
Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.西地那非可改善收缩性心力衰竭患者的运动血流动力学和摄氧量。
Circulation. 2007 Jan 2;115(1):59-66. doi: 10.1161/CIRCULATIONAHA.106.626226. Epub 2006 Dec 18.
6
Determining the best ventilatory efficiency measure to predict mortality in patients with heart failure.确定预测心力衰竭患者死亡率的最佳通气效率指标。
J Heart Lung Transplant. 2006 May;25(5):589-95. doi: 10.1016/j.healun.2005.11.448. Epub 2006 Mar 23.
7
Sildenafil citrate therapy for pulmonary arterial hypertension.枸橼酸西地那非治疗肺动脉高压
N Engl J Med. 2005 Nov 17;353(20):2148-57. doi: 10.1056/NEJMoa050010.
8
A perspective on the muscle reflex: implications for congestive heart failure.肌肉反射的观点:对充血性心力衰竭的影响
J Appl Physiol (1985). 2005 Jul;99(1):5-22. doi: 10.1152/japplphysiol.01405.2004.
9
The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.西地那非抑制磷酸二酯酶-5对慢性心力衰竭患者肺血流动力学、弥散能力、运动通气效率及摄氧动力学的影响
J Am Coll Cardiol. 2004 Dec 21;44(12):2339-48. doi: 10.1016/j.jacc.2004.09.041.
10
Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.心力衰竭患者的峰值摄氧量和VE/VCO2斜率:一项预后比较。
Am Heart J. 2004 Feb;147(2):354-60. doi: 10.1016/j.ahj.2003.07.014.